German Semiconductors Stock News

Bayer (XTRA:BAYN) has opened Q1 2026 with total revenue of €13.4 billion and basic EPS of €2.81, marking a sharp contrast with the loss it reported just a few quarters ago. Over the recent quarters, revenue has moved from €11.4 billion in Q4 2025 and €9.7 billion in Q3 2025 to the latest €13.4 billion, while basic EPS has shifted from a loss of €3.82 in Q4 2025 and a loss of €0.98 in Q3 2025 to a profit of €2.81. This sets up a quarter where margins are firmly back in focus and where the...

If you are wondering whether Siemens at €267.00 is still offering value or already pricing in a lot of optimism, you are not alone. The stock is roughly flat over the last 7 days, but it is up 16.7% over 30 days, 10.7% year to date and 21.7% over 1 year, with longer term returns of 87.1% over 3 years and 127.2% over 5 years. These moves sit against a backdrop where Siemens continues to attract attention in key industrial and infrastructure areas, drawing investors who are watching how large...

Siemens Energy Q2 2026: Earnings Hold Up As Profitability Beds In Siemens Energy (XTRA:ENR) heads into its Q2 2026 earnings discussion with Q1 2026 revenue of €9.7b, basic EPS of €0.79 and net income of €677m setting the tone for the current financial year. Over the past reported periods, revenue has ranged from €8.9b in Q1 2025 to €10.4b in Q4 2025, while basic EPS moved between €0.19 and €0.79 as the business shifted from a loss of €293m in Q4 2024 to consistent profit. With trailing 12...

Carl Zeiss Meditec (XTRA:AFX) reported weaker second quarter and first half 2025/2026 results, with lower sales and net income, and introduced its multi year Profit Up restructuring program targeting more than €200 million in annual profit improvements. See our latest analysis for Carl Zeiss Meditec. Despite the weak first half, the share price has reacted sharply in the short term, with a 1 day share price return of 12.36% and a 30 day share price return of 10.72%, while the 1 year total...

Uniper (XTRA:UN0) opened 2026 on the back of a sharp reset in its earnings profile, with Q4 2025 revenue at about €16.2b and basic EPS of €1.99, against a trailing twelve month line of €61.1b in revenue and EPS of €3.35 that reflects a very large 370.4% earnings gain over the past year. Over the last two reported quarters, revenue has moved from roughly €11.8b in Q3 2025 to €16.2b in Q4 2025, while quarterly EPS shifted from €0.72 to €1.99. This sets up Q1 2026 against a backdrop of higher...

IONOS Group (XTRA:IOS) has just laid out a busy twelve months, with trailing revenue of €1.32b and basic EPS of €1.46, alongside net income from continuing operations of €202.35 million. Quarterly figures over 2024 and 2025 show revenue ranging from €324.98 million to €448.74 million and EPS between €0.24 and €0.47. Over the same stretch, investors have seen revenue move from €1.25b to €1.70b on a trailing basis and basic EPS shift from €0.93 to €1.60, giving a clear view of how the top and...

Prosus has reduced its stake in Delivery Hero (XTRA:DHER), transferring a 5% holding to Aspex Management. The move follows requirements from the European Commission linked to Prosus's broader regulatory obligations. The stake transfer shifts influence toward Aspex Management, an investor associated with more activist engagement. The change in shareholder mix increases pressure on Delivery Hero's board and management over future options. Delivery Hero runs online food delivery and related...

Thyssenkrupp (XTRA:TKA) has just posted Q2 2026 numbers that show revenue of €7.2b and a basic EPS loss of €0.57, with net income excluding extra items at a loss of €353m. Over the prior five reported quarters, revenue has ranged from €7.2b to €8.8b while basic EPS has swung between a loss of €1.70 and a profit of €1.03. This highlights how sensitive earnings have been to shifts in margins and one off items. With analysts in the provided data pointing to strong earnings growth and a recent...

Villeroy & Boch (XTRA:VIB3) has come out of Q4 2025 with total revenue of €371.8 million and net income of €6.2 million, equal to basic EPS of €0.23. On a trailing twelve month basis, revenue sits at €1.45 billion with net income of €14.7 million and EPS of €0.55. Over the last year, revenue on a trailing basis has moved from €1.42 billion to €1.45 billion, alongside earnings growth of 149.2% and a net profit margin that has shifted from 0.4% to 1%. For investors, this mix of higher...

Münchener Rückversicherungs-Gesellschaft in München (XTRA:MUV2) has just posted its Q1 2026 results with quarterly revenue for the most recent reported period at €15.6b and basic EPS at €7.36, set against a trailing twelve month EPS of €47.15 on revenue of €62.3b. Over recent quarters, revenue has moved in a relatively tight band between €14.9b and €16.5b while quarterly EPS ranged from €6.85 to €15.95. This gives you a clear read on how earnings power has translated into a trailing net...

Siemens Healthineers (XTRA:SHL) is back in focus after agreeing a collaboration with HKSH Medical Group to make HKSH the first Photon Counting CT Simulator Reference Site in Asia. This highlights fresh attention on its radiotherapy technology footprint. See our latest analysis for Siemens Healthineers. The HKSH partnership comes after a busy spell that included half year results and a series of investor roadshows in London, Paris and the US. Yet the stock’s 1 month share price return is down...

KWS SAAT SE & Co. KGaA recently reported past third-quarter results showing sales of €937.3 million and net income of €283.8 million, alongside nine-month sales of €1,348.6 million and net income of €220 million to 31 March 2026. While sales edged higher year on year, earnings and basic EPS softened and cash flow felt pressure from higher receivables, even as leverage improved and full-year guidance was confirmed. We’ll now examine how resilient nine-month sales but weaker earnings and cash...

BASF (XTRA:BAS) has drawn fresh attention after first quarter 2026 earnings showed sales of €16,020 million, along with higher net income of €927 million and increased earnings per share compared with a year earlier. See our latest analysis for BASF. Despite a small 1-day share price decline of 0.56% to €53.16 and a 30-day share price return that is down 2.82%, BASF’s year to date share price return of 18.71% and 1-year total shareholder return of 22.41% point to momentum that has built over...

GEA Group (XTRA:G1A) opened 2026 with Q1 revenue of €1.3b and basic EPS of €0.62, as the company reported net income from continuing operations of €100.1m. Over recent quarters, revenue has moved between €1.3b and €1.6b, while basic EPS has ranged from €0.56 to €0.75. This gives investors a clear view of how the top line and per share earnings have been tracking into this latest print. With net margins holding in the mid single digits, the focus now is on how consistently the company can...

MTU Aero Engines (XTRA:MTX) is back in focus after its latest quarterly report, which showed €2,231 million in sales and €200 million in net income, along with updated earnings per share data. See our latest analysis for MTU Aero Engines. The recent earnings release, which combined higher sales with lower net income and earnings per share, came against a share price that is now €295.5 and has fallen 9.83% over 30 days and 20.39% year to date. The 5 year total shareholder return of 48.79%...

The European market has recently experienced a modest uptick, with the pan-European STOXX Europe 600 Index showing gains amid easing geopolitical tensions and strong corporate earnings. However, potential tariff threats from the U.S. have added pressure to the market landscape. In such an environment, dividend stocks can offer investors a measure of stability and income, as they typically represent companies with robust financial health and consistent cash flow generation.

Redcare Pharmacy (XTRA:RDC) drew investor attention after reporting first quarter 2026 results, with sales of €849.5 million versus €717.3 million a year earlier and a net loss of €10.5 million versus €10.8 million. See our latest analysis for Redcare Pharmacy. The latest first quarter results appear to have reset sentiment in the short term, with the share price up 6.93% over one day and 19.05% over 30 days. However, the year to date share price return of 28.48% and 1 year total shareholder...

Recent performance and context for Deutsche Lufthansa With no single headline event driving attention today, Deutsche Lufthansa (XTRA:LHA) is drawing interest as investors weigh recent share performance against the airline group’s current earnings profile and broad international operations. See our latest analysis for Deutsche Lufthansa. The recent 7 day share price return of 8.65% contrasts with a weaker 90 day share price return, which is down 11.92%, while the 1 year total shareholder...

In the first quarter of 2026, Continental Aktiengesellschaft reported sales of €4,396 million versus €4,905 million a year earlier, while net income rose to €200 million from €68 million, alongside confirming plans at its ContiTech division to cut about 3,000 jobs globally, including roughly 1,600 in Germany, under a cost‑saving program. Although quarterly earnings per share increased to €1 from €0.34 despite lower sales, the agreed workforce reductions and related cost measures highlight...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Readers hoping to buy DMG MORI AKTIENGESELLSCHAFT ( ETR:GIL ) for its dividend will need to make their move shortly, as...

It looks like Deutsche Börse AG ( ETR:DB1 ) is about to go ex-dividend in the next 2 days. The ex-dividend date is...

It's been a pretty great week for SAF-Holland SE ( ETR:SFQ ) shareholders, with its shares surging 17% to €20.05 in the...

Wacker Neuson SE ( ETR:WAC ) stock is about to trade ex-dividend in two days. Typically, the ex-dividend date is two...